je.st
news
Gilead's Harvoni accepted in Canadian health plan
2015-03-24 14:20:49| Biotech - Topix.net
" Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators. The recommendation means that both Harvoni and the biotechnology company's Sovaldi are listed for public reimbursement for hepatitis in multiple Canadian provinces.
Tags: health
plan
accepted
canadian
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|